Skip to main content
Log in

Effect of Lycopene Against Cisplatin-Induced Acute Renal Injury in Rats: Organic Anion and Cation Transporters Evaluation

  • Published:
Biological Trace Element Research Aims and scope Submit manuscript

Abstract

In the present study, we investigated the effects of lycopene on the expression of organic anion transporters (OATs), organic cation transporters (OCTs), and multidrug resistance-associated proteins (MRPs) of cisplatin-induced nephrotoxicity in rats. Twenty-eight 8-week-old Wistar rats were divided into four groups: control, lycopene-treated (6 mg/kg BW by oral gavage), cisplatin-treated (7 mg/kg BW, IP), and lycopene in combination with cisplatin-treated groups. In the presence of cisplatin, serum urea nitrogen (urea-N) (48.5 vs. 124.3 mg/dl) and creatinine (0.29 vs. 1.37 mg/dl) levels and the kidney efflux transporters MRP2 and MRP4 levels were significantly increased, whereas OAT1, OAT3, OCT1, and OCT2 levels in kidney were decreased in the treated rats compared with normal control rats. However, administration of lycopene in combination with cisplatin resulted in a reduction in the serum urea-N (124.3 vs. 62.4) and creatinine (1.37 vs. 0.40) levels and the kidney efflux transporters MRP2 and MRP4 proteins in the kidneys. Administration of lycopene to acute renal injury-induced rats largely upregulated the organic anion transporters (OAT1 and 3) and organic cation transporters (OCT1 and 2) to decrease the side effects of cisplatin. The present study suggests that lycopene synergizes with its nephroprotective effect against cisplatin-induced acute kidney injury in rats.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Meyer KB, Medias E (1994) Cisplatin nephrotoxicity. Miner Electrolyte Metab 20:201–213

    CAS  PubMed  Google Scholar 

  2. Luke DR, Vadiei K, Lopez-Berestein G (1992) Role of vascular congestion in cisplatin-induced acute renal failure in the rat. Nephrol Dial Transplant 7:1–7

    CAS  PubMed  Google Scholar 

  3. Kang DG, Lee AS, Mun YJ et al (2004) Butein ameliorates renal concentrating ability in cisplatin-induced acute renal failure in rats. Biol Pharm Bull 27:366–370

    Article  CAS  PubMed  Google Scholar 

  4. Ashrafi F, Haghshenas S, Nematbakhsh M et al (2012) The role of magnesium supplementation in cisplatin-induced nephrotoxicity in a rat model: no nephroprotectant effect. Int J Prev Med 3:637–643

    PubMed Central  PubMed  Google Scholar 

  5. Sahin K, Sahin N, Kucuk O (2010) Lycopene and chemotherapy toxicity. Nutr Cancer 62:988–995

    Article  CAS  PubMed  Google Scholar 

  6. Kim YK, Jung JS, Lee SH et al (1997) Effects of antioxidants and ca2/in cisplatin-induced cell injury in rabbit renal cortical slices. Toxicol Appl Pharmacol 146:261–269

    Article  CAS  PubMed  Google Scholar 

  7. Mora L dO, Antunes LMG, Francescato HDC et al (2003) The effects of oral glutamine on cisplatin-induced nephrotoxicity in rats. Pharmacol Res 47:517–522

    Article  CAS  Google Scholar 

  8. Velmurugan ST, Santhiya ST, Nagini S (2004) Protective effect of S-allylcysteine and lycopene in combination against N-methyl-N′-nitro-N-nitrosoguanidine-induced genotoxicity. Pol J Pharmacol 56:241–245

    Article  CAS  PubMed  Google Scholar 

  9. Tapiero H, Townsend DM, Tew KD (2004) The role of carotenoids in the prevention of human pathologies. Biomed Pharmacother 58:100–110

    Article  CAS  PubMed  Google Scholar 

  10. Cohen LA (2002) A review of animal model studies of tomato carotenoids, lycopene, and cancer chemoprevention. Exp Biol Med 227:864–868

    CAS  Google Scholar 

  11. Kucuk O, Sarkar FH, Sakr W et al (2001) Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiol Biomarkers Prev 10:861–868

    CAS  PubMed  Google Scholar 

  12. Kucuk O (2002) Chemoprevention of prostate cancer. Cancer Metastasis Rev 21:111–124

    Article  CAS  PubMed  Google Scholar 

  13. Kucuk O, Sarkar FH, Djuric Z et al (2002) Effects of lycopene supplementation in patients with localized prostate cancer. Exp Biol Med 227:881–885

    CAS  Google Scholar 

  14. Amin AR, Kucuk O, Khuri FR et al (2009) Perspectives for cancer prevention with natural compounds. J Clin Oncol 27:2712–2725

    Article  PubMed Central  PubMed  Google Scholar 

  15. Seren S, Lieberman R, Bayraktar UD et al (2008) Lycopene in cancer prevention and treatment. Am J Ther 15:66–81

    Article  PubMed  Google Scholar 

  16. Yilmaz S, Atessahin A, Sahna E et al (2006) Protective effect of lycopene on adriamycin-induced cardiotoxicity and nephrotoxicity. Toxicology 218:164–171

    Article  CAS  PubMed  Google Scholar 

  17. Dogukan A, Tuzcu M, Agca CA et al (2011) A tomato lycopene complex protects the kidney from cisplatin-induced injury via affecting oxidative stress as well as Bax, Bcl-2, and HSPs expression. Nutr Cancer 63:427–434

    Article  CAS  PubMed  Google Scholar 

  18. Atessahin A, Yilmaz S, Karahan I et al (2005) Effects of lycopene against cisplatin-induced nephrotoxicity and oxidative stress in rats. Toxicology 212:116–123

    Article  CAS  PubMed  Google Scholar 

  19. Endou H (1998) Recent advances in molecular mechanisms of nephrotoxicity. Toxicol Lett 28:29–33

    Article  Google Scholar 

  20. Inui KI, Masuda S, Saito H (2000) Cellular and molecular aspects of drug transport in the kidney. Kidney Int 58:944–958

    Article  CAS  PubMed  Google Scholar 

  21. Roch-Ramel F, Besseghir K, Murer H (1992) Renal excretion and tubular transport of organic anions and cations. In: Windhager EE (ed) Renal physiology, handbook of physiology, 2nd edn. Oxford University Press, New York, pp 2189–2262

    Google Scholar 

  22. Ullrich KJ (1994) Specificity of transporters for ‘organic anions’ and ‘organic cations’ in the kidney. Biochim Biophys Acta 1197:45–62

    Article  CAS  PubMed  Google Scholar 

  23. Launay-Vacher V, Izzedine H, Karie S et al (2006) Renal tubular drug transporters. Nephron Physiol 103:97–106

    Article  Google Scholar 

  24. Morisaki T, Matsuzaki T, Yokoo K et al (2008) Regulation of renal organic ion transporters in cisplatin-induced acute kidney injury and uremia in rats. Pharm Res 25:2526–2533

    Article  CAS  PubMed  Google Scholar 

  25. Huang Q, Dunn RT 2nd, Jayadev S et al (2001) Assessment of cisplatin-induced nephrotoxicity by microarray technology. Toxicol Sci 63:196–207

    Article  CAS  PubMed  Google Scholar 

  26. Demeule M, Brossard M, Beliveau R (1999) Cisplatin induces renal expression of P-glycoprotein and canalicular multispecific organic anion transporter. Am J Physiol 277:832–840

    Google Scholar 

  27. Ulu R, Dogukan A, Tuzcu M et al (2012) Regulation of renal organic anion and cation transporters by thymoquinone in cisplatin induced kidney injury. Food Chem Toxicol 50:1675–1679

    Article  CAS  PubMed  Google Scholar 

  28. Shimeda Y, Hirotani Y, Akimoto Y et al (2005) Protective effects of capsaicin against cisplatin-induced nephrotoxicity in rats. Biol Pharm Bull 28:1635–1638

    Article  CAS  PubMed  Google Scholar 

  29. Sung MJ, Kim DH, Jung YJ et al (2008) Genistein protects the kidney from cisplatin-induced injury. Kidney Int 4:1538–1547

    Article  Google Scholar 

  30. Farombi EO, Shrotriya S, Na HK et al (2008) Curcumin attenuates dimethylnitrosamine-induced liver injury in rats through Nrf2-mediated induction of heme oxygenase-1. Food Chem Toxicol 46:1279–1287

    Article  CAS  PubMed  Google Scholar 

  31. Sahin K, Tuzcu M, Gencoglu H et al (2010) Epigallocatechin-3-gallate activates Nrf2/HO-1 signaling pathway in cisplatin-induced nephrotoxicity in rats. Life Sci 87:240–245

    Article  CAS  PubMed  Google Scholar 

  32. Sun H, Frassetto L, Benet LZ (2006) Effects of renal failure on drug transport and metabolism. Pharmacol Ther 109:1–11

    Article  CAS  PubMed  Google Scholar 

  33. Nowicki MT, Aleksunes LM, Sawant SP et al (2008) Renal and hepatic transporter expression in type 2 diabetic rats. Drug Metab Lett 2:11–17

    Article  CAS  PubMed  Google Scholar 

  34. Aleksunes LM, Augustine LM, Scheffer GL et al (2008) Renal xenobiotic transporters are differentially expressed in mice following cisplatin treatment. Toxicology 250:82–88

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

The authors thank the Turkish Academy of Sciences (TUBA) for supporting (in part) this study.

Conflict of Interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kazim Sahin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Erman, F., Tuzcu, M., Orhan, C. et al. Effect of Lycopene Against Cisplatin-Induced Acute Renal Injury in Rats: Organic Anion and Cation Transporters Evaluation. Biol Trace Elem Res 158, 90–95 (2014). https://doi.org/10.1007/s12011-014-9914-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12011-014-9914-x

Keywords

Navigation